Interestingly, in patient-derived GSCs, the mRNA expression of STAT3, CEBPB and TAZ was blocked by IκBα-SR, suggesting that in GBM, master mesenchymal transcription factors are regulated by NF-κB [13]. This evidence concerns the gene NFKB1 and glioblastoma.